Prevention we can afford
This is the third of a three-part op-ed series exploring how simple, affordable prevention could change the trajectory of the opioid epidemic — if we have the will to act.
Pharmacy
2026 Health Care Outlook: Michael Hogue, APhA
By Michael Hogue, executive vice president and CEO of the American Pharmacists Association
2026 Health Care Outlook: Susan Cantrell, AMCP
By Susan Cantrell, CEO, Academy of Managed Care Pharmacy
2026 Health Care Outlook: Scott Melville, CHPA
By Scott Melville, president and CEO of the Consumer Healthcare Products Association
2026 Health Care Outlook: Peter Matz, FMI – The Food Industry Association
By Peter Matz, Director of Food, Pharmacy and Health Policy at FMI – The Food Industry Association
2026 Health Care Outlook: Chip Davis, HDA
By Chester “Chip” Davis Jr. is president and CEO of the Healthcare Distribution Alliance
Strive sues Eli Lilly and Novo Nordisk over GLP-1 access
Strive Compounding Pharmacy accuses drugmakers of anti-competitive actions to suppress lawful compounded GLP-1 medications and restrict patient choice.
2026 Health Care Outlook: Sheila Arquette, NASP
By Sheila Arquette, president and CEO of the National Association of Specialty Pharmacy
2026 Health Care Outlook: John Murphy III, AAM
By John Murphy III, president and CEO of the Association for Accessible Medicines
2026 Health Care Outlook: Steve Anderson, NACDS
By Steve Anderson, president and CEO of the National Association of Chain Drug Stores
2026 Health Care Outlook: Doug Hoey, NCPA
By Doug Hoey, CEO, National Community Pharmacists Association
2026 Health Care Outlook: Lee Ann Stember, NCPDP
By Lee Ann Stember, president and CEO of NCPDP
CVS Health Foundation grants the American Diabetes Association $2.6 million for programs in NYC
The initiative will scale evidence-based solutions to improve pregnancy and postpartum outcomes for New Yorkers.
RFK Jr. names two OB-GYNs to CDC’s ACIP
These appointments reflect the commitment of Secretary Robert F. Kennedy, Jr. to transparency, gold standard science, and diverse expertise in guiding the nation’s immunization policies.
Surescripts and GoodRx team to advance patient price transparency
“We believe the future of health care is personalized, connected and truly patient-driven,” said Frank Harvey, CEO of Surescripts.